Emerging Medical Treatments for Meningioma in the Molecular Era

Emerging Medical Treatments for Meningioma in the Molecular Era

Meningiomas are the most common type of primary central nervous system tumors. Approximately, 80% of meningiomas are classified by the World Health Organization (WHO) as grade I, and 20% of these tumors are grade II and III, considered high-grade meningiomas (HGMs). Clinical control of HGMs, as well...

Full description

Bibliographic Details
Main Authors: Fares Nigim, Hiroaki Wakimoto, Ekkehard M. Kasper, Linda Ackermans, Yasin Temel
Format: Article
Language:English
Published: MDPI AG 2018-08-01
Series:Biomedicines
Subjects:
World Health Organization (WHO)
Grade I, II, and III Meningiomas
High Grade Meningiomas (HGMs)
tumor heterogeneity
genetic subtypes
overall survival (OS)
progression free survival (PFS)
targeted therapy
clinical trials
oncolytic virus (OV)
Online Access:http://www.mdpi.com/2227-9059/6/3/86

Internet

http://www.mdpi.com/2227-9059/6/3/86

Similar Items